Clinical Trial Update: Clinical and Virological Efficacy of Pegylated Interferon Alpha in the Treatment of Rhinovirus Infection in Patients With Primary Hypogammaglobulinemia: Randomized Controlled Trial [Phase 2]

View source ↗

Summary

A phase 2 randomized controlled trial evaluating the clinical and virological efficacy of pegylated interferon alpha for rhinovirus infection in patients with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinovirus Infection

Drugs mentioned

• Pegylated interferon alpha (Pegylated interferon alfa)

Snippet

Sponsor: Turku University Hospital | Conditions: Rhinovirus Infection | Phase 2 | Status: UNKNOWN